Therapeutic advances for the tumors associated with neurofibromatosis type 1, type 2, and schwannomatosis von Blakeley, Jaishri O, Plotkin, Scott R

Volltext

Updated diagnostic criteria and nomenclature for neurofibromatosis type 2 and schwannomatosis: An international consensus recommendation von Plotkin, Scott R., Messiaen, Ludwine, Legius, Eric, Pancza, Patrice, Avery, Robert A., Blakeley, Jaishri O., Babovic-Vuksanovic, Dusica, Ferner, Rosalie, Fisher, Michael J., Friedman, Jan M., Giovannini, Marco, Gutmann, David H., Hanemann, Clemens Oliver, Kalamarides, Michel, Kehrer-Sawatzki, Hildegard, Korf, Bruce R., Mautner, Victor-Felix, MacCollin, Mia, Papi, Laura, Rauen, Katherine A., Riccardi, Vincent, Schorry, Elizabeth, Smith, Miriam J., Stemmer-Rachamimov, Anat, Stevenson, David A., Ullrich, Nicole J., Viskochil, David, Wimmer, Katharina, Yohay, Kaleb, Huson, Susan M., Wolkenstein, Pierre, Evans, Dafydd Gareth

Volltext

Expanding therapeutic options for people with NF2-related schwannomatosis: Encouraging results with brigatinib von Plotkin, Scott R, Blakeley, Jaishri O

Volltext

Clinical Features of Schwannomatosis: A Retrospective Analysis of 87 Patients von Merker, Vanessa L., Esparza, Sonia, Smith, Miriam J., Stemmer‐Rachamimov, Anat, Plotkin, Scott R.

Volltext

Measuring the Effect of Cutaneous Neurofibromas on Quality of Life in Neurofibromatosis Type 1 von Maguiness, Sheilagh, Berman, Yemima, Rubin, Nathan, Dodds, Melissa, Plotkin, Scott R., Wong, Claire, Moertel, Christopher

Volltext

Quantitative assessment of whole-body tumor burden in adult patients with neurofibromatosis von Plotkin, Scott R, Bredella, Miriam A, Cai, Wenli, Kassarjian, Ara, Harris, Gordon J, Esparza, Sonia, Merker, Vanessa L, Munn, Lance L, Muzikansky, Alona, Askenazi, Manor, Nguyen, Rosa, Wenzel, Ralph, Mautner, Victor F

Volltext

Bevacizumab treatment for meningiomas in NF2: a retrospective analysis of 15 patients von Nunes, Fabio P, Merker, Vanessa L, Jennings, Dominique, Caruso, Paul A, di Tomaso, Emmanuelle, Muzikansky, Alona, Barker, 2nd, Fred G, Stemmer-Rachamimov, Anat, Plotkin, Scott R

Volltext

Phase II trial of sunitinib for recurrent and progressive atypical and anaplastic meningioma von Kaley, Thomas J, Wen, Patrick, Schiff, David, Ligon, Keith, Haidar, Sam, Karimi, Sasan, Lassman, Andrew B, Nolan, Craig P, DeAngelis, Lisa M, Gavrilovic, Igor, Norden, Andrew, Drappatz, Jan, Lee, Eudocia Quant, Purow, Benjamin, Plotkin, Scott R, Batchelor, Tracy, Abrey, Lauren E, Omuro, Antonio

Volltext

The Use of MEK Inhibitors in Neurofibromatosis Type 1–Associated Tumors and Management of Toxicities von Klesse, Laura J., Jordan, Justin T., Radtke, Heather B., Rosser, Tena, Schorry, Elizabeth, Ullrich, Nicole, Viskochil, David, Knight, Pamela, Plotkin, Scott R., Yohay, Kaleb

Volltext

Improved tumor oxygenation and survival in glioblastoma patients who show increased blood perfusion after cediranib and chemoradiation von Batchelor, Tracy T., Gerstner, Elizabeth R., Emblem, Kyrre E., Duda, Dan G., Kalpathy-Cramer, Jayashree, Snuderl, Matija, Ancukiewicz, Marek, Polaskova, Pavlina, Pinho, Marco C., Jennings, Dominique, Plotkin, Scott R., Chi, Andrew S., Eichler, April F., Dietrich, Jorg, Hochberg, Fred H., Lu-Emerson, Christine, lafrate, A. John, Ivy, Percy, Rosen, Bruce R., Loeffler, Jay S., Wen, Patrick Y., Sorensen, Greg, Jain, Rakesh K.

Volltext

Safety and efficacy of tisagenlecleucel in primary CNS lymphoma: a phase 1/2 clinical trial von Frigault, Matthew J., Dietrich, Jorg, Gallagher, Kathleen, Roschewski, Mark, Jordan, Justin T., Forst, Deborah, Plotkin, Scott R., Cook, Daniella, Casey, Keagan S., Lindell, Kevin A., Depinho, Gabriel D., Katsis, Katelin, Elder, Eva Lynn, Leick, Mark B., Choi, Bryan, Horick, Nora, Preffer, Frederic, Saylor, Meredith, McAfee, Steven, O'Donnell, Paul V., Spitzer, Thomas R., Dey, Bimalangshu, DeFilipp, Zachariah, El-Jawahri, Areej, Batchelor, Tracy T., Maus, Marcela V., Chen, Yi-Bin

Volltext

Efficacy and Biomarker Study of Bevacizumab for Hearing Loss Resulting From Neurofibromatosis Type 2-Associated Vestibular Schwannomas von Blakeley, Jaishri O, Ye, Xiaobu, Duda, Dan G, Halpin, Chris F, Bergner, Amanda L, Muzikansky, Alona, Merker, Vanessa L, Gerstner, Elizabeth R, Fayad, Laura M, Ahlawat, Shivani, Jacobs, Michael A, Jain, Rakesh K, Zalewski, Christopher, Dombi, Eva, Widemann, Brigitte C, Plotkin, Scott R

Volltext

Evolving concepts in meningioma management in the era of genomics von Hsieh, Annie L., Bi, Wenya Linda, Ramesh, Vijaya, Brastianos, Priscilla K., Plotkin, Scott R.

Volltext

Multicenter, Prospective, Phase II and Biomarker Study of High-Dose Bevacizumab as Induction Therapy in Patients With Neurofibromatosis Type 2 and Progressive Vestibular Schwannoma von Plotkin, Scott R, Duda, Dan G, Muzikansky, Alona, Allen, Jeffrey, Blakeley, Jaishri, Rosser, Tena, Campian, Jian L, Clapp, D Wade, Fisher, Michael J, Tonsgard, James, Ullrich, Nicole, Thomas, Coretta, Cutter, Gary, Korf, Bruce, Packer, Roger, Karajannis, Matthias A

Volltext

Increased Risk of Cerebrovascular Disease Among Patients With Neurofibromatosis Type 1: Population-Based Approach von Terry, Anna R, Jordan, Justin T, Schwamm, Lee, Plotkin, Scott R

Volltext

Phase II Study of Cediranib, an Oral Pan–Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor, in Patients With Recurrent Glioblastoma von BATCHELOR, Tracy T, DUDA, Dan G, LOUIS, David N, COHEN, Kenneth S, CHEA, Houng, EXARHOPOULOS, Alexis, LOEFFLER, Jay S, MOSES, Marsha A, IVY, Percy, SORENSEN, A. Gregory, WEN, Patrick Y, JAIN, Rakesh K, DI TOMASO, Emmanuelle, ANCUKIEWICZ, Marek, PLOTKIN, Scott R, GERSTNER, Elizabeth, EICHLER, April F, DRAPPATZ, Jan, HOCHBERG, Fred H, BENNER, Thomas

Volltext

NF2/Merlin Is a Novel Negative Regulator of mTOR Complex 1, and Activation of mTORC1 Is Associated with Meningioma and Schwannoma Growth von James, Marianne F., Han, Sangyeul, Polizzano, Carolyn, Plotkin, Scott R., Manning, Brendan D., Stemmer-Rachamimov, Anat O., Gusella, James F., Ramesh, Vijaya

Volltext

Cutaneous neurofibromas: Current clinical and pathologic issues von Ortonne, Nicolas, Wolkenstein, Pierre, Blakeley, Jaishri O, Korf, Bruce, Plotkin, Scott R, Riccardi, Vincent M, Miller, Douglas C, Huson, Susan, Peltonen, Juha, Rosenberg, Andrew, Carroll, Steven L, Verma, Sharad K, Mautner, Victor, Upadhyaya, Meena, Stemmer-Rachamimov, Anat

Volltext

Neurofibromatosis Clinical Trials—REiNS Collaboration 2020 Recommendations: Looking Back and Moving Ahead von Gross, Andrea M., Plotkin, Scott R., Widemann, Brigitte C.

Volltext

NF106: A Neurofibromatosis Clinical Trials Consortium Phase II Trial of the MEK Inhibitor Mirdametinib (PD-0325901) in Adolescents and Adults With NF1-Related Plexiform Neurofibrom... von Weiss, Brian D, Wolters, Pamela L, Plotkin, Scott R, Widemann, Brigitte C, Tonsgard, James H, Blakeley, Jaishri, Allen, Jeffrey C, Schorry, Elizabeth, Korf, Bruce, Robison, Nathan J, Goldman, Stewart, Vinks, Alexander A, Emoto, Chie, Fukuda, Tsuyoshi, Robinson, Coretta T, Cutter, Gary, Edwards, Lloyd, Dombi, Eva, Ratner, Nancy, Packer, Roger, Fisher, Michael J

Volltext